Evidence map›Paper›PMID 31977084›Full record

ArticleCancer2020

Associations between nutritional factors and chemotherapy toxicity in older adults with solid tumors.

Efrat Dotan, William P Tew, Supriya G Mohile, Huiyan Ma, Heeyoung Kim, Can-Lan Sun, Bette Caan, William Dale, Ajeet Gajra, Heidi D Klepin and 6 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 11 institutions in 1 country.

Efrat DotanDepartment of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.ORCID 0000-0002-5762-512X
William P TewDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Supriya G MohileUniversity of Rochester Medical Center, Rochester, New York.
Huiyan MaCity of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, California.
Heeyoung KimCity of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, California.
Can-Lan SunCity of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, California.
Bette CaanDivision of Research, Kaiser Permanente Medical Program of North California, Oakland, California.
William DaleCity of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, California.ORCID 0000-0001-8674-9394
Ajeet GajraCardinal Health, Dublin, Ohio.
Heidi D KlepinWake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina.
Cynthia OwusuCase Western Comprehensive Cancer Center, Cleveland, Ohio.
Cary P GrossYale School of Medicine, New Haven, Connecticut.ORCID 0000-0002-4974-935X
Hyman MussLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Andrew ChapmanJefferson Senior Adult Oncology Center, Sidney Kimmel Cancer Center, Jefferson Health System, Philadelphia, Pennsylvania.
Vani KatheriaCity of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, California.
Arti HurriaCity of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, California.ORCID 0000-0001-7983-9615
City of Hope · USAtrium Health Wake Forest Baptist · USCardinal Health (United States) · USFox Chase Cancer Center · USKaiser Permanente · USMemorial Sloan Kettering Cancer Center · USSidney Kimmel Cancer Center · USUniversity Hospitals Seidman Cancer Center · USUniversity of North Carolina at Chapel Hill · USUniversity of Rochester Medical Center · USYale University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Dietmar J Kappes · 1985 to 2026
$138.8M
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
URCC NCORP Research BaseUG1CA189961 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, KAREN M. MUSTIAN · 2014 to 2026
$67.7M
Tumor Tissue CoreP30CA012197 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Ruben A. Mesa · 1985 to 2026
$55.4M
Wake Forest Claude D. Pepper OAIC - RenewalP30AG021332 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Denise Kathryn Houston · 2002 to 2026
$36.4M
Geriatric Oncology Research Infrastructure to Improve Clinical CareR33AG059206 · NIA · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI WILLIAM DALE, Heidi Diana Klepin · 2020 to 2026
$5.1M
A Patient-Oriented Research Program in Geriatric OncologyK24AG056589 · NIA · UNIVERSITY OF ROCHESTER · PI Supriya G. Mohile · 2018 to 2026
$1.5M
Mentoring the Next Generation of Geriatric Oncology Researchers in Patient-Oriented Research to Improve the Care of Older Adults with CancerK24AG055693 · NIA · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI WILLIAM DALE · 2018 to 2026
$1.4M
Can Geriatric Assessment Predict Oncology Outcomes?K23AG026749 · NIA · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI HURRIA, ARTI · 2005 to 2009
$874k
Minimizing Physical Function Decline in Older Adults Receiving ChemotherapyK23AG038361 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI KLEPIN, HEIDI DIANA · 2011 to 2014
$562k
Geriatric Oncology Research Infrastructure to Improve Clinical CareR21AG059206 · NIA · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI DALE, WILLIAM, MOHILE, SUPRIYA G. · 2018 to 2019
$478k
NCATS NIH HHS UL1 TR001863NCI NIH HHS P30 CA006927NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA012197NCI NIH HHS UG1 CA189961NIA NIH HHS K23 AG026749NIA NIH HHS K23 AG038361NIA NIH HHS K24 AG055693NIA NIH HHS K24 AG056589NIA NIH HHS P30 AG021332NIA NIH HHS R21 AG059206NIA NIH HHS R33 AG059206
6 · The paper itself

Abstract

backgroundNutritional status can directly affect morbidity and mortality in older adults with cancer. This study evaluated the association between pretreatment body mass index (BMI), albumin level, and unintentional weight loss (UWL) in the prior 6 months and chemotherapy toxicity among older adults with solid tumors.

methodsThis was a secondary analysis of a prospective, multicenter study involving chemotherapy-treated patients 65 years old or older. Geriatric assessment, BMI, albumin level, and UWL data were collected before treatment. Multivariable logistic regression models evaluated the associations between nutritional factors and the risk of grade 3 or higher (grade 3+) chemotherapy toxicity.

resultsSeven hundred fifty patients with a median age of 72 years (range, 65-94 years) and mostly stage IV disease were enrolled. The median pretreatment BMI and albumin values were 26 kg/m

conclusionsAmong older adults with solid tumors, higher BMIs and normal albumin levels are associated with a lower risk of grade 3+ chemotherapy toxicity. Additional research is warranted to define the clinical significance of nutritional markers and to inform future interventions.

Indexed as

AgedAged, 80 and overAntineoplastic AgentsBiomarkersBody Mass IndexFemaleGeriatric AssessmentHumansLogistic ModelsMaleNeoplasmsNutritional StatusProspective StudiesSerum AlbuminAntineoplastic AgentsBiomarkersSerum Albuminalbuminbody mass index (BMI)chemotherapy tolerancenutritional statusolder patients

Identifiers

PMID31977084
PMCPMC7494013
OpenAlexW3001411335

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.